{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:15:53Z","timestamp":1789114553519,"version":"build-2803163510"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the effects of propranolol on the malignant biological behaviours of renal cancer cells and explore the potential involvement of the IL-6\/PI3K\/AKT signalling axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      786-O and Caki-2 ccRCC cells were treated with gradient propranolol, followed by CCK-8, wound-healing, Transwell and flow cytometry assays to test cell proliferation, migration, invasion and apoptosis. Western blot was applied to measure proteins associated with apoptosis, EMT, IL-6 and PI3K\/AKT pathway. A xenograft nude mouse model was constructed to verify propranolol\u2019s anti-tumor activity\n                      <jats:italic>in vivo<\/jats:italic>\n                      . RNA-seq combined with GO\/KEGG enrichment was used to screen underlying signaling pathways. IL-6 overexpression rescue assays were performed to validate IL-6\u2019s functional role in propranolol-mediated phenotypes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Propranolol significantly inhibited the proliferation, migration and invasion of 786-O and Caki-2 cells and induced apoptosis in a concentration-dependent manner. Propranolol upregulated Bax, cleaved-Caspase-3, cleaved-Caspase-9, E-cadherin and TIMP2, while downregulating Bcl-2, N-cadherin, Vimentin and MMP9, suggesting enhanced apoptosis and suppression of EMT- and invasion-related phenotypes.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , propranolol delayed xenograft tumour growth and reduced final tumour volume and weight. RNA-seq identified 984 differentially expressed genes, including 464 upregulated and 520 downregulated genes. Functional enrichment analysis showed that these genes were mainly associated with extracellular matrix remodelling, cytokine activity, hypoxia response, lipid metabolism and tumour-related pathways, including the PI3K\/AKT signalling pathway. Western blotting confirmed that propranolol decreased the p-PI3K\/PI3K and p-AKT\/AKT ratios. In addition, propranolol reduced IL-6 protein expression in renal cancer cells, whereas IL-6 overexpression partially restored propranolol-suppressed cell proliferation, migration and invasion, and partially reversed propranolol-induced changes in apoptosis-related proteins, EMT-related proteins and PI3K\/AKT pathway activation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Propranolol suppresses the malignant biological behaviours of renal cancer cells and inhibits renal tumour growth\n                      <jats:italic>in vivo<\/jats:italic>\n                      . These effects may be mediated, at least in part, through downregulation of IL-6 and suppression of PI3K\/AKT signalling pathway activation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1884603","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:20:49Z","timestamp":1789111249000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Propranolol attenuates the malignant biological behaviors of renal cancer cells partly through modulation of the IL-6\/PI3K\/AKT signaling axis"],"prefix":"10.3389","volume":"17","author":[{"given":"Dongming","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Urology, Sanming First Hospital Affiliated to Fujian Medical University","place":["Sanming, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Urology, Sanming First Hospital Affiliated to Fujian Medical University","place":["Sanming, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Sanming First Hospital Affiliated to Fujian Medical University","place":["Sanming, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Sanming First Hospital Affiliated to Fujian Medical University","place":["Sanming, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Urology, Sanming First Hospital Affiliated to Fujian Medical University","place":["Sanming, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangfan","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Urology, Sanming First Hospital Affiliated to Fujian Medical University","place":["Sanming, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, Sanming First Hospital Affiliated to Fujian Medical University","place":["Sanming, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13023-015-0343-5","article-title":"Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients","volume":"10","author":"Albi\u00f1ana","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.3390\/jcm9092740","article-title":"Targeting \u03b22-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from Von Hippel-Lindau disease","volume":"9","author":"Albi\u00f1ana","year":"2020","journal-title":"J. Clin. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/ijms23031325","article-title":"Blockade of \u03b22-adrenergic receptor reduces inflammation and oxidative stress in clear cell renal cell carcinoma","volume":"23","author":"Albi\u00f1ana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/19336918.2017.1307482","article-title":"IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells","volume":"12","author":"Chen","year":"2018","journal-title":"Cell. Adhesion and Migr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"120320","DOI":"10.1016\/j.lfs.2022.120320","article-title":"KIR2DL4 promotes the proliferation of RCC cell associated with PI3K\/Akt signalling activation","volume":"293","author":"Ding","year":"2022","journal-title":"Life Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41388-021-02170-0","article-title":"Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumour microenvironment","volume":"41","author":"Fj\u00e6stad","year":"2022","journal-title":"Oncogene"},{"key":"B7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/19768354.2019.1658638","article-title":"Prognostic role of the beta-2 adrenergic receptor in clear cell renal cell carcinoma","volume":"23","author":"Ha","year":"2019","journal-title":"Animal Cells Syst."},{"key":"B8","doi-asserted-by":"publisher","first-page":"628613","DOI":"10.3389\/fonc.2021.628613","article-title":"Clinical use of propranolol reduces biomarkers of proliferation in gastric cancer","volume":"11","author":"Hu","year":"2021","journal-title":"Front. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.ajpath.2024.02.022","article-title":"TFE3\/PI3K\/Akt\/mTOR axis in renal cell carcinoma affects tumour microenvironment","volume":"194","author":"Hwang","year":"2024","journal-title":"Am. J. Pathology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10120-021-01184-7","article-title":"Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis","volume":"24","author":"Koh","year":"2021","journal-title":"Gastric Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40779-025-00661-9","article-title":"Reprogramming neural-tumour crosstalk: emerging therapeutic dimensions and targeting strategies","volume":"12","author":"Liu","year":"2025","journal-title":"Mil. Med. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12967-024-05354-w","article-title":"IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6\/PI3K\/AKT axis","volume":"22","author":"Lu","year":"2024","journal-title":"J. Transl. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fonc.2020.00625","article-title":"Impact of extracellular matrix components to renal cell carcinoma behavior","volume":"10","author":"Majo","year":"2020","journal-title":"Front. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00432-025-06262-2","article-title":"Does propranolol have a role in cancer treatment? A systematic review of the epidemiological and clinical trial literature on beta-blockers","volume":"151","author":"O'Logbon","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00262-018-2243-8","article-title":"\u03b2-Adrenergic signalling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress","volume":"68","author":"Qiao","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3171\/2018.5.JNS172879","article-title":"Repurposing propranolol as an antitumour agent in von Hippel-Lindau disease","volume":"131","author":"Shepard","year":"2018","journal-title":"J. Neurosurg."},{"key":"B18","first-page":"2957","article-title":"Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation","volume":"62","author":"Turner","year":"2002","journal-title":"Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3892\/mmr.2021.12406","article-title":"Regulation of the PTEN\/PI3K\/AKT pathway in RCC using the active compounds of natural products in vitro","volume":"24","author":"Wang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2207029","DOI":"10.1002\/smll.202207029","article-title":"Leveraging \u03b2-adrenergic receptor signalling blockade for improved cancer immunotherapy through biomimetic nanovaccine","volume":"19","author":"Yang","year":"2023","journal-title":"Small"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1038\/onc.2010.270","article-title":"RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma","volume":"29","author":"Zhang","year":"2010","journal-title":"Oncogene"},{"key":"B22","doi-asserted-by":"publisher","first-page":"105070","DOI":"10.1016\/j.ebiom.2024.105070","article-title":"VHL mutation drives human clear cell renal cell carcinoma progression through PI3K\/AKT-dependent cholesteryl ester accumulation","volume":"103","author":"Zhang","year":"2024","journal-title":"EBioMedicine"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1884603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:20:50Z","timestamp":1789111250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1884603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":22,"alternative-id":["10.3389\/fphar.2026.1884603"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1884603","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1884603"}}